Our members

Alcea

Alcea is a modern pharmaceutical company headquartered in Moscow, one of top-3 pharmaceutical companies in address market of women's health in the Russian market*.

Previously part of Acino International, since November 2023 it has been operating in Russia as an independent business under a new brand.

Alcea's portfolio includes high-quality medicines and supplements that are designed to support women’s and men’s health throughout their lives (among the most popular of them are Indinol Forto, Posterisan, Neo-Penotran group of medicines, Ferretab, Estrovel, Cervikon-DIM.

Under Acino brand the company operated in Russia since 2015, but in general its history in the domestic market dates back to 2012.

More information on website https://alceapharma.ru/.

* IQVIA Database, Retail Segment, Trd Price RUB, Address market (competitive group formed on the basis of expert assessment of players with similar indications), January - September, 2023.

Bayer

Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to help people and planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to drive sustainable development and generate a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2020, the Group employed around 100,000 people and had sales of 41.4 billion euros. R&D expenses before special items amounted to 4.9 billion euros.

Haleon

Haleon business combines trusted science and human understanding to create innovative everyday healthcare brands that consumers trust and experts recommend across oral health, pain relief, cold, flu and allergy, digestive health and vitamins, minerals and supplements.
The portfolio of loved and trusted brands includes Sensodyne, parodontax, Otrivin, Theraflu, Voltaren, Corega, Fenistil and Bifiform.

Johnson & Johnson Consumer Health

Johnson & Johnson comprises 265 companies located in more than 60 countries with more than 130,000 employees. Johnson & Johnson's Consumer Health division helps over 1.2 billion people around the world lead healthier lives every day from day one. From baby baths and cuts and scrapes to sun protection and soothing soreness, consumers have found Johnson & Johnson's innovative solutions useful for more than 130 years. A differentiated portfolio of brands such as JOHNSON'S®, NEUTROGENA®, AVEENO®, LISTERINE®, OGX®, LE PETIT MARSEILLAIS®, HEXORAL®, DOCTOR MOM®, IMODIUM®, METROGYL DENTA®, MICROLAX®, MOTILIGAS®, MOTILIUM®, MOTRIN ®, NICORETTE®, RINZA®, TYZINE®, VISINE® and many more combines the power of science with a deep understanding of people's needs to help consumers take care of themselves and those they love.

Johnson & Johnson Vision

At Johnson & Johnson Vision, part of Johnson & Johnson MedTech, as a leader in eye health, we have a bold ambition: Vision Made Possible — paving the way for a new future of eye health to support the full spectrum of pediatric, adult and aging eyes. Through cutting-edge innovation, scientific expertise, and advanced technologies, we are transforming the way patients see and experience the world. At every step of the eye health journey, we stand as a trusted partner, making dependable outcomes possible for customers and patients. And, in communities with greatest need, we work in collaboration to expand access to quality eye care—for all.